Useful Biomarkers for the Diagnosis of Endometriosis
|
|
Kim, Sun-Young
(Department of Obstetrics and Gynecology, College of Medicine, Yonsei University, Gangnam Severance Hospital)
Lee, Byung-Seok (Department of Obstetrics and Gynecology, College of Medicine, Yonsei University, Gangnam Severance Hospital) |
| 1 | Liaw L, Skinner MP, Raines EW, Ross R, Cheresh DA, Schwartz SM, Giachelli CM. The adhesive and migratory effects of osteopontin are mediated via distinct cell surface integrins. Role of alpha v beta 3 in smooth muscle cell migration to osteopontin in vitro. J Clin Invest 1995; 95: 713 -24. DOI ScienceOn |
| 2 | Apparao KB, Murray MJ, Fritz MA, Meyer WR, Chambers AF, Truong PR, Lessey BA. Osteopontin and its receptor alpha v beta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab 2001; 86: 4991-5000. DOI ScienceOn |
| 3 | Marcoux S, Maheux R, Berube S. Laparoscopic surgery in infertile women with minimal or mild endometriosis. Canadian Collaborative Group on Endometriosis. N Engl J Med 1997; 337: 217-22. DOI ScienceOn |
| 4 | Dheenadayalu K, Mak I, Gordts S, Campo R, Higham J, Puttemans P, et al. Aromatase P450 messenger RNA expressionin eutopic endometrium is not a specific marker for pelvic endometriosis. Fertil Steril 2002; 78: 825-9. DOI ScienceOn |
| 5 | Mai KT, Yazdi HM, Perkins DG, Parks W. Pathogenetic role of the stromal cells in endometriosis and adenomyosis. Histopathology 1997; 30: 430-42. DOI ScienceOn |
| 6 | Reinholt FP, Hultenby K, Oldberg A, Heinegard D. Osteopontin - a possible anchor of osteoclasts to bone. Proc Natl Acad Sci USA 1990; 87: 4473-5. DOI ScienceOn |
| 7 | Koprowski H, Steplewski Z, Mitchell K, Herlyn M, Herlyn D, Fuhrer P. Colorectal carcinoma antigens detected by hybridoma antibodies. Somat Cell Genet 1979; 5: 957-71. DOI ScienceOn |
| 8 | Harada T, Yoshioka H, Yoshida S, Iwabe T, Onohara Y, Tanikawa M, et al. Increased interleukin-6 levels in peritoneal fluid of infertile patients with active endometriosis. Am J Obstet Gynecol 1997; 176: 593-7. DOI ScienceOn |
| 9 | Kao LC, Tulac S, Lobo S, Imani B, Yang JP, Germeyer A, et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002; 143: 2119-38. DOI ScienceOn |
| 10 | Matalliotakis IM, Vassiliadis S, Goumenou AG, Athanassakis I, Koumantakis GE, Neonaki MA, et al. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment. J Reprod Immunol 2001;51: 9-19. DOI ScienceOn |
| 11 | Cho SH, Ahn YS, Choi YS, Seo SK, Nam A, Kim HY, et al. Endometrial osteoponin mRNA expression and Plasma osteopontin levels are increased in patients with endometriosis. Am J Reprod Immunol 2009; 61: 286-93. DOI ScienceOn |
| 12 | Koyama N, Matsuura K, Okamura H. Cytokines in the peritoneal fluid of patients with endometriosis. Int J Gynaecol Obstet 1993; 43: 45-50. DOI ScienceOn |
| 13 | Taylor RN, Ryan IP, Moore ES, Hornung D, Shifren JL, Tseng JF. Angiogenesis and macrophage activation in endometriosis. Ann N Y Acad Sci 1997; 828: 194-207. DOI |
| 14 | Braun DP, Ding J, Dmowski WP. Peritoneal fluid-mediated enhancement of eutopic and ectopic endometrial cell proliferation is dependent on tumor necrosis factor-alpha in women with endometriosis. Fertil Steril 2002; 78: 727-32. DOI ScienceOn |
| 15 | Hu DD, Lin EC, Kovach NL, Hoyer JR, Smith JW. A biochemical characterization of the binding of osteopontin to integrins alpha v beta 1 and alpha v beta 5. J Biol Chem 1995; 270: 26232-38. DOI ScienceOn |
| 16 | Odagiri K, Konno R, Fujiwara H, Netsu S, Ohwada M, Shibahara H, Suzuki M. Immunohistochemical study of osteopontin and L-selectin in a rat endometriosis model and in human endometriosis. Fertil Steril 2007; 88: 1207-11. DOI ScienceOn |
| 17 | Hunt JS, Chen HL, Hu XL, Tabibzadeh S. Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium. Biol Reprod 1992; 47: 141-7. DOI ScienceOn |
| 18 | Nothnick WB. Treating endometriosis as an autoimmune disease. Fertil Steril 2001; 76: 223-31, 17: 426-31. |
| 19 | Laird SM, Li TC, Bolton AE. The production of placental protein 14 and interleukin 6 by human endometrial cells in culture. Hum Reprod 1993; 8: 793-8. DOI |
| 20 | Rier SE, Parsons AK, Becker JL. Altered interleukin-6 production by peritoneal leukocytes from patients with endometriosis. Fertil Steril 1994; 61: 294-9. DOI |
| 21 | Takayama K, Zeitoun K, Gunby RT, Sasano H, Carr BR, Bulun SE. Treatment of severe postmenopausal endometriosis with an aromatase inhibitor. Fertil Steril 1998; 69: 709-13. DOI ScienceOn |
| 22 | Nisolle M, Casanas-Roux F, Donnez J. Immunohistochemical analysis of proliferative activity and steroid receptor expression in peritoneal and ovarian endometriosis. Fertil Steril 1997; 68: 912-9. DOI ScienceOn |
| 23 | Jiang J, Wu R, Wang Z, Sun H, Xu Z, Xiu H. Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro. Fertil Steril 2002; 77: 995-1000. DOI ScienceOn |
| 24 | Eisermann J, Gast MJ, Pineda J, Odem RR, Collins JL.Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. Fertil Steril 1988; 50: 573-9. DOI |
| 25 | Evers JL, Dunselman GA, Van der Linden PJ. Markers for endometriosis. Baillieres Clin Obstet Gynaecol 1993; 7: 715 -39. DOI ScienceOn |
| 26 | Brown LF, Berse B, Van de Water L, Papadopoulos-Sergiou A, Perruzzi CA, Manseau EJ, Dvorak HF, Senger DR. Expression and distribution of osteopontin in human tissues: widespread association with luminal epithelial surfaces. Mol Biol Cell 1992; 3: 1169-80. DOI |
| 27 | Rodrigues LR, Teixeira JA, Schmitt FL, Paulsson M, Lindmark-Mansson H. The role of osteopontin in tumor progression and metastasis in breast cancer. Cancer Epidemiol Biomarkers Prev 2007; 16: 1087-97. DOI ScienceOn |
| 28 | Kitawaki J, Noguchi T, Amatsu T, Maeda K, Tsukamoto K, Yamamoto T, et al. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biol Reprod 1997; 57: 514-9. DOI ScienceOn |
| 29 | Bulun SE, Zeitoun K, Takayama K, Noble L, Michael D, Simpson E, et al. Estrogen production in endometriosis and use of aromatase inhibitors to treat endometriosis. Endocr Relat Cancer 1999; 6: 293-301. DOI ScienceOn |
| 30 | Bedaiwy MA, Falcone T, Sharma RK, Goldberg JM, Attaran M, Nelson DR, et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. Hum Reprod 2002; 17: 426-31. DOI ScienceOn |
| 31 | Van Langendonckt A, Casanas-Roux F, Donnez J. Iron overload in the peritoneal cavity of women with pelvic endometriosis. Fertil Steril 2002; 78: 712-8. DOI ScienceOn |
| 32 | Philippeaux MM, Piguet PF. Expression of tumor necrosis factor-alpha and its mRNA in the endometrial mucosa during the menstrual cycle. Am J Pathol 1993; 143: 480-6. |
| 33 | Syrop CH, Halme J. Peritoneal fluid environment and infertility. Fertil Steril 1987; 48: 1-9. |
| 34 | Matthews CJ, Redfern CP, Hirst BH, Thomas EJ. Character ization of human purified epithelial and stromal cells from endometrium and endometriosis in tissue culture. Fertil Steril 1992; 57: 990-7. DOI |
| 35 | Zeitoun KM, Bulun SE. Aromatase: a key molecule in the pathophysiology of endometriosis and a therapeutic target. Fertil Steril 1999; 72: 961-9. DOI ScienceOn |
| 36 | Bulun SE, Zeitoun KM, Takayama K, Simpson E, Sasano H. Aromatase as a therapeutic target in endometriosis. Trends Endocrinol Metab 2000; 11: 22-7. DOI ScienceOn |
| 37 | Bouquet de Joliniere J, Validire P, Canis M, Doussau M, Levardon M, Gogusev J. Human endometriosis-derived permanent cell line (FbEM-1): establishment and characterization. Hum Reprod Update 1997; 3: 117-23. DOI ScienceOn |
| 38 | Simon C, Frances A, Piquette GN, el Danasouri I, Zurawski G, Dang W, et al. Embryonic implantation in mice is blocked by interleukin-1 receptor antagonist. Endocrinology 1994; 134: 521-8. DOI ScienceOn |
| 39 | Taketani Y, Kuo TM, Mizuno M. Comparison of cytokine levels and embryo toxicity in peritoneal fluid in infertile women with untreated or treated endometriosis. Am J Obstet Gynecol 1992; 167: 265-70. DOI ScienceOn |
| 40 | Syrop CH, Halme J. Cyclic changes of peritoneal fluid parameters in normal and infertile patients. Obstet Gynecol 1987; 69: 416-8. |
| 41 | Halme J, Becker S, Wing R. Accentuated cyclic activation of peritoneal macrophages in patients with endometriosis. Am J Obstet Gynecol 1984; 148: 85-90. DOI |
| 42 | Yan SF, Fujita T, Lu J, Okada K, Shan Zou Y, Mackman N, et al. Egr-1, a master switch coordinating upregulation of divergent gene families underlying ischemic stress. Nat Med 2000; 6: 1355-61. DOI ScienceOn |
| 43 | Stefansson H, Geirsson RT, Steinthorsdottir V, Jonsson H, Manolescu A, Kong A, et al. Genetic factors contribute to the risk of developing endometriosis. Hum Reprod 2002; 17: 555 -9. DOI ScienceOn |
| 44 | Taylor RN, Lundeen SG, Giudice LC. Emerging role of genomics in endometriosis research. Fertil Steril 2002; 78: 694-8. DOI ScienceOn |
| 45 | Vaisse C, Atger M, Potier B, Milgrom E. Human placental protein 14 gene: sequence and characterization of a short duplication. DNA Cell Biol 1990; 9: 401-13. DOI ScienceOn |
| 46 | Yan SF, Pinsky DJ, Mackman N, Stern DM. Egr-1: is it always immediate and early? J Clin Invest 2000; 105: 553-4. DOI ScienceOn |
| 47 | Vidal F, Aragones J, Alfranca A, de Landazuri MO. Upregulation of vascular endothelial growth factor receptor Flt-1 after endothelial denudation: role of transcription factor Egr-1. Blood 2000; 95: 3387-95. |
| 48 | Eyster KM, Boles AL, Brannian JD, Hansen KA. DNA microarray analysis of gene expression markers of endometriosis. Fertil Steril 2002; 77: 38-42. DOI ScienceOn |
| 49 | Cho SH, Oh YJ, Nam A, Kim HY, Park JH, Kim JH, et al. Evaluation of serum and urinary angiogenic factors in patients with endometriosis. Am J Reprod Immunol 2007; 58: 497-504. DOI ScienceOn |
| 50 | Kumar H, Heer K, Greenman J, Kerin MJ, Monson JR. Soluble FLT-1 is detectable in the sera of colorectal and breast cancer patients. Anticancer Res 2002; 22: 1877-80. |
| 51 | Hsu CC, Yang BC, Wu MH, Huang KE. Enhanced interleukin- 4 expression in patients with endometriosis. Fertil Steril 1997; 67: 1059-64. DOI ScienceOn |
| 52 | Tsudo T, Harada T, Iwabe T, Tanikawa M, Nagano Y, Ito M, et al. Altered gene expression and secretion of interleukin-6 in stromal cells derived from endometriotic tissues. Fertil Steril 2000; 73: 205-11. DOI ScienceOn |
| 53 | Ilhan N, Ilhan N, Deveci F. Functional significance of vascular endothelial growth factor and its receptor (receptor-1) in various lung cancer types. Clin Biochem 2004; 37: 840-5. DOI ScienceOn |
| 54 | Somigliana E, Vigano P, Candiani M, Felicetta I, Di Blasio AM, Vignali M. Use of serum-soluble intercellular adhesion molecule-1 as a new marker of endometriosis. Fertil Steril 2002; 77: 1028-31. DOI ScienceOn |
| 55 | Taylor RN, Levoric DI, Mueller MD. Angiogenic factors in endometriosis. Ann N Y Acad Sci 2002; 955: 90-100. |
| 56 | Aref S, El Sherbiny M, Goda T, Fouda M, Al Askalany H, Abdalla D: Soluble VEGF / sFLt1 ratio is an independent predictor of AML patient outcome. Hematology 2005; 10: 131-4. DOI ScienceOn |
| 57 | Wu MH, Yang BC, Hsu CC, Lee YC, Huang KE. The expression of soluble intercellular adhesion molecule-1 in endometriosis. Fertil Steril 1998; 70: 1139-42. DOI ScienceOn |
| 58 | Harada T, Kubota T, Aso T. Usefulness of CA19-9 versus CA 125 for the diagnosis of endometriosis. Fertil Steril 2002; 78: 733-9. DOI ScienceOn |
| 59 | Vigano P, Somigliana E, Gaffuri B, Santorsola R, Busacca M, Vignali M. Endometrial release of soluble intercellular adhesion molecule 1 and endometriosis: relationship to the extent of the disease. Obstet Gynecol 2000; 95: 115-8. DOI ScienceOn |
| 60 | De Placido G, Alviggi C, Di Palma G, Carravetta C, Matarese G, Landino G, et al. Serum concentrations of soluble human leukocyte class I antigens and of the soluble intercellular adhesion molecule-1 in endometriosis: relationship with stage and non-pigmented peritoneal lesions. Hum Reprod 1998; 13: 3206-10. DOI |
| 61 | Daniel Y, Geva E, Amit A, Eshed-Englender T, Baram A, Fait G, et al. Do soluble cell adhesion molecules play a role in endometriosis? Am J Reprod Immunol 2000; 43: 160-6. DOI ScienceOn |
| 62 | Barbati A, Cosmi EV, Spaziani R, Ventura R, Montanino G. Serum and peritoneal fluid CA-125 levels in patients with endometriosis. Fertil Steril 1994; 61: 438-42. DOI |
| 63 | Cho SH, Cho HB, Nam A, Kim HY, Choi YS, Park KH, et al. Neutrophil-to-lymphocyte ratio as an adjunct to CA 125 for the diagnosis of endometriosis. Fertil Steril 2008; 90: 2073-9. DOI ScienceOn |
| 64 | Matalliotakis I, Panidis D, Vlassis G, Neonaki M, Goumenou A, Koumantakis E. Unexpected increase of the CA 19-9 tumour marker in patients with endometriosis. Eur J Gynaecol Oncol 1998; 19: 498-500. |
| 65 | De Angulo G, Yuen C, Palla SL, Anderson PM, Zweidler- McKay PA. Absolute lymphocyte count is a novel prognostic indicator in ALL and AML: implications for risk stratification and future studies. Cancer 2008; 112: 407-15. DOI ScienceOn |
| 66 | Walsh SR, Cook EJ, Goulder F, Justin TA, Keeling NJ. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol 2005; 91: 181-4. DOI ScienceOn |
| 67 | Fedele L, Arcaini L, Vercellini P, Bianchi S, Candiani GB. Serum CA 125 measurements in the diagnosis of endometriosis recurrence. Obstet Gynecol 1988; 72: 19-22. |
| 68 | Zahorec R. Ratio of neutrophil to lymphocyte counts-rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102: 5-14. |
| 69 | Bishara S, Griffin M, Cargill A, Bali A, Gore ME, Kaye SB, et al. Pretreatment white blood cell subtypes as prognostic indicators in ovarian cancer. Eur J Obstet Gynecol Reprod Biol. Published online 17 July 2007 [epub ahead of print; http://dx.doi.org/10.1016/j.ejogrb.2007.05.012]. |
| 70 | Moretuzzo RW, DiLauro S, Jenison E, Chen SL, Reindollar RH, McDonough PG. Serum and peritoneal lavage fluid CA-125 levels in endometriosis. Fertil Steril 1988; 50: 430-3. DOI |
| 71 | Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al. The performance of CA-125 measurement in the detection of endometriosis: a metaanalysis. Fertil Steril 1998; 70: 1101-8. DOI ScienceOn |
| 72 | Revised American Fertility Society classification of endometriosis. Fertil Steril 1985; 43: 351-2. DOI |
| 73 | Hornung D, Ryan IP, Chao VA, Vigne JL, Schriock ED, Taylor RN. Immunolocalization and regulation of the chemokine RANTES in human endometrial and endometriosis tissues and cells. J Clin Endocrinol Metab 1997; 82: 1621-8. DOI ScienceOn |
| 74 | Pittaway DE, Rondinone D, Miller KA, Barnes K. Clinical evaluation of CA-125 concentrations as a prognostic factor for pregnancy in infertile women with surgically treated endometriosis. Fertil Steril 1995; 64: 321-4. DOI |
| 75 | Meden H, Fattahi-Meibodi A. CA 125 in benign gynecological conditions. Int J Biol Markers 1998; 13: 231-7. DOI |
| 76 | Donnez J, Smoes P, Gillerot S, Casanas-Roux F, Nisolle M. Vascular endothelial growth factor (VEGF) in endometriosis. Hum Reprod 1998; 13: 1686-90. DOI ScienceOn |
| 77 | Ortiz BD, Krensky AM, Nelson PJ. Kinetics of transcription factors regulating the RANTES chemokine gene reveal a developmental switch in nuclear events during T-lymphocyte maturation. Mol Cell Biol 1996; 16: 202-10. DOI |
| 78 | Pittaway DE, Fayez JA. Serum CA-125 antigen levels increase during menses. Am J Obstet Gynecol 1987; 156: 75-6. DOI |
| 79 | Pittaway DE, Fayez JA. The use of CA-125in the diagnosis and management of endometriosis. Fertil Steril 1986; 46: 790 -5. DOI |
| 80 | Lebovic DI, Mueller MD, Taylor RN. Vascular endothelial growth factor in reproductive biology. Curr Opin Obstet Gynecol 1999; 11: 255-60. DOI ScienceOn |
| 81 | Tseng JF, Ryan IP, Milam TD, Murai JT, Schriock ED, Landers DV, et al. Interleukin-6 secretion in vitro is upregulated in ectopic and eutopic endometrial stromal cells from women with endometriosis. J Clin Endocrinol Metab 1996; 81: 1118-22. DOI |
| 82 | D'Angelo G, Struman I, Martial J, Weiner RI. Activation of mitogen-activated protein kinases by vascular endothelial growth factor and basic fibroblast growth factor in capillary endothelial cells is inhibited by the antiangiogenic factor 16-kDa N-terminal fragment of prolactin. Proc Natl Acad Sci USA 1995; 92: 6374-8. DOI ScienceOn |
| 83 | Dvorak HN, Senger DR, Dvorak AM, Harvey VS, McDonagh J. Regulation of extravascular coagulation bmicrovascular permeability. Science 1985; 227: 1059-61. DOI |
| 84 | Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, et al. Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 1996; 81: 3112-8. DOI ScienceOn |
 |
Korea Institute of Science and Technology Information
Gwahangno, Yuseong-gu, Daejeon, 305-806, Korea TEL : +82-42-869-1752
Copyright (c) 2009 KISTI. All Rights Reserved. For more information mail to
webmaster
